Byetta was FDA-approved in 2005, Victoza was approved in 2010, and Saxenda was approved in 2014
One less common but disturbing potential side effect of the drug, which is sold under the brand names Ozempic and Wegovy: Hair loss
As a result, 503B facilities often assign longer BUDs, sometimes 60-90 days or more, because they have the data to support those extended dates
The changes of mitophagy were reflected by detecting cytochrome c oxidase subunit II (COXII), LC3II/LC3I, mitochondria, and autophagosomes
While the timing is similar, some research suggests that tirzepatide may have a slightly different side effect profile due to the GIP component, which may help mitigate some of the nausea for certain individuals